ID   MEL-SLM2
AC   CVCL_ZL70
SY   SLM2; SLM2-Mel; SLM-2; Storkus Lab Melanoma no. 2
DR   GEO; GSM1671961
DR   GEO; GSM1671968
DR   GEO; GSM1672005
DR   GEO; GSM1672072
DR   GEO; GSM1672079
DR   GEO; GSM1672093
DR   GEO; GSM1672108
DR   GEO; GSM1672113
DR   GEO; GSM1672133
DR   Wikidata; Q98127224
RX   PubMed=12631591;
CC   Omics: Transcriptome analysis by microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
RX   PubMed=12631591;
RA   Tatsumi T., Kierstead L.S., Ranieri E., Gesualdo L., Schena F.P.,
RA   Finke J.H., Bukowski R.M., Brusic V., Sidney J., Sette A., Logan T.F.,
RA   Kasamon Y.L., Slingluff C.L. Jr., Kirkwood J.M., Storkus W.J.;
RT   "MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+
RT   T cells from patients with melanoma or renal cell carcinoma.";
RL   Clin. Cancer Res. 9:947-954(2003).
//